Oladiran Oreoluwa, Dhital Rashmi, Donato Anthony
Internal Medicine, Reading Hospital, Tower Health System, PA, USA.
J Community Hosp Intern Med Perspect. 2018 Aug 23;8(4):244-245. doi: 10.1080/20009666.2018.1500422. eCollection 2018.
Autoimmune hemolytic anemia (AIHA) is a condition associated with an extensive differential diagnosis that includes lymphoid malignancies. Although AIHA occurs in about 10-25% of patients with chronic lymphocytic leukemia, it is also reported to occur in all of the other lymphoid subtypes. In this article, we report a case of recurrent AIHA in a 67-year-old woman with two acute episodes of hemolysis separated by 3 years of hematologic remission. Both episodes were severe enough to require blood transfusion, oral steroids, and rituximab. Bone marrow biopsy and immunophenotyping using flow cytometry done during both admissions confirmed the presence of splenic marginal zone lymphoma.
自身免疫性溶血性贫血(AIHA)是一种鉴别诊断范围广泛的疾病,其中包括淋巴系统恶性肿瘤。尽管AIHA在约10%-25%的慢性淋巴细胞白血病患者中出现,但据报道在所有其他淋巴亚型中也有发生。在本文中,我们报告了一例67岁女性复发性AIHA病例,该患者有两次急性溶血发作,中间间隔3年血液学缓解期。两次发作均严重到需要输血、口服类固醇和利妥昔单抗治疗。两次住院期间进行的骨髓活检和流式细胞术免疫表型分析均证实存在脾边缘区淋巴瘤。